Blood pressure management during aortic surgery: urapidil compared to isosorbide dinitrate

Area of Science:

• Cardiovascular Surgery
• Anesthesiology
• Pharmacology

Background:

• Abdominal aortic surgery presents significant hemodynamic challenges.
• Maintaining blood pressure and optimizing oxygen delivery are critical during aortic clamping and declamping.
• Urapidil (arteriolar vasodilator) and isosorbide dinitrate (venodilator) are used for blood pressure control.

Purpose of the Study:

• To compare the efficacy and hemodynamic effects of urapidil versus isosorbide dinitrate for blood pressure control during abdominal aortic surgery.
• To evaluate the impact of these agents on cardiac index, systemic vascular resistance, and oxygen delivery.

Main Methods:

• A randomized study comparing urapidil and isosorbide dinitrate in 18 patients each undergoing abdominal aortic surgery.
• Hemodynamic parameters (heart rate, blood pressure, cardiac index, systemic vascular resistance) were recorded at multiple time points.
• Arterial and mixed venous oxygen content differences were compared.

Main Results:

• Both drugs achieved similar heart rate and blood pressure profiles.
• Urapidil significantly decreased systemic vascular resistance and increased cardiac index compared to isosorbide dinitrate.
• Urapidil administration led to a higher cardiac index post-aortic clamping and an improved arterio-venous oxygen content difference.

Conclusions:

• Urapidil is an effective and safe agent for preventing hemodynamic instability during abdominal aortic surgery.
• Urapidil improves cardiac output and oxygen delivery, offering advantages over venodilators like isosorbide dinitrate in this surgical context.